Found: 68
Select item for more details and to access through your institution.
Influence of Taxanes on Treatment Sequence in Gastric Cancer.
- Published in:
- Oncology Research & Treatment, 2020, v. 43, n. 1/2, p. 42, doi. 10.1159/000503428
- By:
- Publication type:
- Article
Patients with Advanced Pancreatic Cancer and Hyperbilirubinaemia: Review and German Expert Opinion on Treatment with nab-Paclitaxel plus Gemcitabine.
- Published in:
- Oncology Research & Treatment, 2015, v. 38, n. 11, p. 596, doi. 10.1159/000441310
- By:
- Publication type:
- Article
Afatinib with Concurrent Radiotherapy in a Patient with Metastatic Non-Small Cell Lung Cancer.
- Published in:
- Oncology Research & Treatment, 2014, v. 37, n. 5, p. 262, doi. 10.1159/000362488
- By:
- Publication type:
- Article
Nab-Paclitaxel for Metastatic Pancreatic Cancer: Clinical Outcomes and Potential Mechanisms of Action.
- Published in:
- Oncology Research & Treatment, 2014, v. 37, n. 3, p. 128, doi. 10.1159/000358890
- By:
- Publication type:
- Article
Quality of life and pain relief in men with metastatic castration-resistant prostate cancer on cabazitaxel: the non-interventional 'QoLiTime' study.
- Published in:
- BJU International, 2017, v. 119, n. 5, p. 731, doi. 10.1111/bju.13658
- By:
- Publication type:
- Article
One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor.
- Published in:
- JAMA: Journal of the American Medical Association, 2012, v. 307, n. 12, p. 1265, doi. 10.1001/jama.2012.347
- By:
- Publication type:
- Article
Ramucirumab plus irinotecan / leucovorin / 5-FU versus ramucirumab plus paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy: the phase II/III RAMIRIS study (AIO-STO-0415)
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11004-z
- By:
- Publication type:
- Article
Targeting Epithelial Growth Factor Receptor (EGFR) With Cetuximab in Combination With Irinotecan as Salvage Treatment in Refractory Gastric Cancer Patients: A Retrospective Analysis and Review of the Literature.
- Published in:
- European Journal of Clinical & Medical Oncology, 2012, v. 4, n. 1, p. 11
- By:
- Publication type:
- Article
Targeting Epithelial Growth Factor Receptor (EGFR) With Cetuximab in Combination With Irinotecan as Salvage Treatment in Refractory Gastric Cancer Patients: A Retrospective Analysis and Review of the Literature.
- Published in:
- European Journal of Clinical & Medical Oncology, 2011, v. 3, n. 1, p. 1
- By:
- Publication type:
- Article
Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer: The Randomized Multicenter Phase II NEPAFOX Trial.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2024, v. 31, n. 6, p. 4073, doi. 10.1245/s10434-024-15011-7
- By:
- Publication type:
- Article
Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3.
- Published in:
- British Journal of Cancer, 2022, v. 127, n. 5, p. 836, doi. 10.1038/s41416-022-01854-y
- By:
- Publication type:
- Article
Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 161, n. 1, p. 63, doi. 10.1007/s10549-016-4033-3
- By:
- Publication type:
- Article
German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer.
- Published in:
- Gastric Cancer, 2024, v. 27, n. 1, p. 6, doi. 10.1007/s10120-023-01424-y
- By:
- Publication type:
- Article
Patient-reported outcomes from the phase II FAST trial of zolbetuximab plus EOX compared to EOX alone as first-line treatment of patients with metastatic CLDN18.2+ gastroesophageal adenocarcinoma.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 3, p. 721, doi. 10.1007/s10120-020-01153-6
- By:
- Publication type:
- Article
Exposure--response relationship of ramucirumab in East Asian patients from RAINBOW: a randomized clinical trial in secondline treatment of gastric cancer.
- Published in:
- Gastric Cancer, 2018, v. 21, n. 2, p. 276, doi. 10.1007/s10120-017-0737-2
- By:
- Publication type:
- Article
Reply to the Letter to the Editor.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Quality of life of older adult patients receiving docetaxel-based chemotherapy triplets for esophagogastric adenocarcinoma: a randomized study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
- Published in:
- Gastric Cancer, 2014, v. 17, n. 1, p. 181, doi. 10.1007/s10120-013-0242-1
- By:
- Publication type:
- Article
Prognostic Impact of Phosphorylated Mitogen-Activated Protein Kinase Expression in Patients with Metastatic Gastric Cancer.
- Published in:
- Oncology, 2011, v. 80, n. 1/2, p. 130, doi. 10.1159/000329063
- By:
- Publication type:
- Article
Reduced Incidence of Severe Palmar-Plantar Erythrodysesthesia and Mucositis in a Prospective Multicenter Phase II Trial with Pegylated Liposomal Doxorubicin at 40 mg/m Every 4 Weeks in Previously Treated Patients with Metastatic Breast Cancer.
- Published in:
- Oncology, 2006, v. 70, n. 2, p. 141, doi. 10.1159/000093005
- By:
- Publication type:
- Article
RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV.
- Published in:
- 2020
- By:
- Publication type:
- journal article
CabaGast: multicentre, Phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the esophagogastric junction and stomach.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 3, p. 559, doi. 10.1007/s00432-017-2565-5
- By:
- Publication type:
- Article
HER2 testing in gastric cancer: results of a German expert meeting.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 5, p. 835, doi. 10.1007/s00432-017-2374-x
- By:
- Publication type:
- Article
Toward a Treatment Sequencing Strategy: A Systematic Review of Treatment Regimens in Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma.
- Published in:
- Oncologist, 2021, v. 26, n. 10, p. e1704, doi. 10.1002/onco.13907
- By:
- Publication type:
- Article
Clinical Practice Observation of Trastuzumab in Patients with Human Epidermal Growth Receptor 2‐Positive Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction.
- Published in:
- Oncologist, 2020, v. 25, n. 8, p. e1181, doi. 10.1634/theoncologist.2020-0109
- By:
- Publication type:
- Article
The Role of Radiation Therapy for Resectable Adenocarcinoma of the Gastroesophageal Junction.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
Evaluation of EGFR inhibitor‐mediated acneiform skin toxicity within the double‐blind randomized EVITA trial: A thorough gender‐specific analysis using the WoMo score.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 9, p. 4169, doi. 10.1002/cam4.2132
- By:
- Publication type:
- Article
Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma--a phase II trial of the AIO study group (AIO STO 0321).
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1272175
- By:
- Publication type:
- Article
The validation of a novel method combining both HER2 immunohistochemistry and HER2 dual-colour silver in situ hybridization on one slide for gastric carcinoma testing.
- Published in:
- Journal of Translational Medicine, 2014, v. 12, n. 1, p. 1, doi. 10.1186/1479-5876-12-160
- By:
- Publication type:
- Article
The validation of a novel method combining both HER2 immunohistochemistry and HER2 dual-colour silver in situ hybridization on one slide for gastric carcinoma testing.
- Published in:
- 2014
- By:
- Publication type:
- journal article
PSA response to cabazitaxel is associated with improved progression-free survival in metastatic castration-resistant prostate cancer: the non-interventional QoLiTime study.
- Published in:
- World Journal of Urology, 2018, v. 36, n. 3, p. 375, doi. 10.1007/s00345-017-2138-x
- By:
- Publication type:
- Article
Real-world comparative effectiveness of nab-paclitaxel plus gemcitabine versus FOLFIRINOX in advanced pancreatic cancer: a systematic review.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919850367
- By:
- Publication type:
- Article
Real-world comparative effectiveness of nab-paclitaxel plus gemcitabine versus FOLFIRINOX in advanced pancreatic cancer: a systematic review.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919850367
- By:
- Publication type:
- Article
A phase 1/2a study to test the safety and immunogenicity of a p16(INK4a) peptide vaccine in patients with advanced human papillomavirus-associated cancers.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 15, p. 2325, doi. 10.1002/cncr.28669
- By:
- Publication type:
- Article
Impact of Chemotherapy on Quality of Life in Patients With Metastatic Esophagogastric Cancer.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 11, p. 2511, doi. 10.1002/cncr.25064
- By:
- Publication type:
- Article
Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma - the phase III "PREVENT"- (FLOT9) trial of the AIO /CAOGI /ACO.
- Published in:
- BMC Cancer, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12885-021-08872-8
- By:
- Publication type:
- Article
Mitomycin C and capecitabine in pretreated patients with metastatic gastric cancer: a multicenter phase II study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2014, v. 140, n. 5, p. 829, doi. 10.1007/s00432-014-1619-1
- By:
- Publication type:
- Article
Metastatic esophagogastric adenocarcinoma: trends in first-line treatment and predictive factors for the implementation of HER2 testing in clinical practice during the first year after trastuzumab market approval.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 2, p. 337, doi. 10.1007/s00432-012-1335-7
- By:
- Publication type:
- Article
Multimodal Treatment Strategies in Esophagogastric Junction Cancer: a Western Perspective.
- Published in:
- Journal of Gastric Cancer, 2019, v. 19, n. 2, p. 148, doi. 10.5230/jgc.2019.19.e19
- By:
- Publication type:
- Article
Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient Data.
- Published in:
- Journal of Gastric Cancer, 2017, v. 17, n. 2, p. 132, doi. 10.5230/jgc.2017.17.e16
- By:
- Publication type:
- Article
VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-476
- By:
- Publication type:
- Article
VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
- Published in:
- 2014
- By:
- Publication type:
- journal article
The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer.
- Published in:
- BMC Cancer, 2012, v. 12, n. 1, p. 524, doi. 10.1186/1471-2407-12-524
- By:
- Publication type:
- Article
Perspectives on the Management of Oligometastatic Disease in Esophago-Gastric Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5200, doi. 10.3390/cancers14215200
- By:
- Publication type:
- Article
Sarcopenia as a prognostic factor for survival in patients with locally advanced gastroesophageal adenocarcinoma.
- Published in:
- PLoS ONE, 2019, v. 14, n. 10, p. 1, doi. 10.1371/journal.pone.0223613
- By:
- Publication type:
- Article
SNAI2/SLUG and estrogen receptor mRNA expression are inversely correlated and prognostic of patient outcome in metastatic non-small cell lung cancer.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1310-1
- By:
- Publication type:
- Article
SNAI2/SLUG and estrogen receptor mRNA expression are inversely correlated and prognostic of patient outcome in metastatic non-small cell lung cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Efficacy of ramucirumab combination chemotherapy as second‐line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first‐line therapy.
- Published in:
- International Journal of Cancer, 2024, v. 154, n. 12, p. 2142, doi. 10.1002/ijc.34894
- By:
- Publication type:
- Article